Valeant Pharmaceuticals International Inc creditors prepare to slam company with tougher demands in face of possible default: sources

Posted by & filed under Company Analysis, Financial analysis, Governments & Regulators, Growth & Valuation.

Description: NEW YORK – Creditors of Valeant Pharmaceuticals International, which has been in violation of lender agreements since Wednesday, are beginning to demand new terms that could further pressure the drugmaker’s business model, according to three people familiar with the matter. Source: Reuter.com/FinancialPost.com Date: Mar 21, 2016 Link: https://business.financialpost.com/investing/market-moves/valeant-pharmaceuticals-international-inc-creditors-prepare-to-slam-company-with-tougher-demands-in-face-of-default-sources Questions for Discussions: Do you think… Read more »

Would You Pay 25 Cents to Read an Article? Blendle Certainly Thinks So

Posted by & filed under Company Analysis, Financial analysis, Industry Analysis.

Description: BLENDLE IS A Dutch media startup that lets you pay a few cents for individual news articles online—the much chattered-about micropayments model that’s one of many on a long list of strategies destined to save the business of journalism (or not). And now it’s available in the US. Source: Wired.com Date: Mar 23, 2016… Read more »

After $600 Million Typo, Valeant CEO Is Back on the Hot Seat

Posted by & filed under Company Analysis, Financial analysis, Governments & Regulators, Growth & Valuation.

Description: Michael Pearson and his company, Valeant Pharmaceuticals International Inc., were supposed to calm Wall Street doubters on Tuesday. Instead: chaos. Source: Bloomberg.com – video report Date: Mar 15, 2016 Link: https://www.bloomberg.com/news/articles/2016-03-15/after-a-600-million-typo-valeant-s-ceo-is-back-on-the-hot-seat Questions for Discussions: Summarize the reasons for Valeant’s share value collapse, according to the report. Do you think it has collapsed completely and… Read more »

‘Fickle’ millennials blamed for Chipotle’s downward spiral

Posted by & filed under Company Analysis, Financial analysis, Governments & Regulators, Growth & Valuation, Industry Analysis, Management Issues.

Description: Chipotle downgrade to rare underperform rating at Jefferies, which cited weak February trends and rising marketing costs Source: MarketWatch.com Date: Mar 18, 2016 Link: https://www.marketwatch.com/story/chipotle-stock-drops-after-rare-bearish-call-at-jefferies-2016-03-17 Questions for Discussions: Why has Chipotle stock been down-graded by this analyst? Do you agree with the assessment and predictions for recovery?

The Lone Analyst Who Said Sell Valeant When Hedge Funds Piled In

Posted by & filed under Company Analysis, Financial analysis, Governments & Regulators, Growth & Valuation.

Description: In July 2014, Dimitry Khmelnitsky advised investors to sell Valeant Pharmaceuticals International Inc. and then watched the stock double in a year. “It was very painful,” Khmelnitsky, an analyst at Veritas Investment Research Corp., said in an telephone interview from his office in Toronto. “What I felt was pain.” Source: Bloomberg.com – video report Date:… Read more »

This investor thinks big banks are doomed

Posted by & filed under Financial analysis, Growth & Valuation, Industry Analysis.

Description: Bond king Bill Gross is not known for his sunny outlook for the markets. But he took his pessimism to a new level in his latest monthly outlook. Source: CNNMoney.com – video report Date: Mar 03, 2016 Link: https://money.cnn.com/2016/03/03/investing/bill-gross-janus-banks-stocks/index.html?iid=hp-stack-dom Questions for discussion: Summarize the bank problems as argued in the report. What do you… Read more »

Fitbit’s Game Plan For Making Your Company Healthy

Posted by & filed under Company Analysis, Financial analysis, Growth & Valuation, Management Issues.

Description: Given how things often go in Silicon Valley, Fitbit shouldn’t be here. It started selling wearable activity trackers when other hardware startups struggled for funding. Source: Forbes.com Date: Jan 08, 2016 Link: https://www.forbes.com/sites/parmyolson/2016/01/08/fitbit-wearables-corporate-wellness/ Questions for Discussions: Summarize the reasons for the firm’s financial success. How secure is the connection with corporate wellness? Should the… Read more »